Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Case Report
Consensus Statement
Editorial
Erratum
Guest Editorial
History
Image
Images in Clinical Practice
Invited Commentary
JSSTD Symposium
Letter to Editor
Letter to the Editor
Letter to the Editor - Study Letter
Net Case
Net Image
Net Letter
Original Article
Resident’s Page
Review Article
Study Letter
Study Letter Case Series
View/Download PDF

Translate this page into:

JSSTD Symposium
3 (
1
); 5-6
doi:
10.25259/JSSTD_4_2021

Symposium editorial: Secondary lymphedema

Department of Dermatology and Venereology, Government Medical College, Thrissur, Kerala, India
Corresponding author: V. G. Binesh, Department of Dermatology and Venereology, Government Medical College, Thrissur, Kerala, India. drbineshvg@gmail.com
Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

How to cite this article: Binesh VG. Symposium editorial: Secondary lymphedema. J Skin Sex Transm Dis 2021;3(1):5-6.

Edema, which, in fact, is excess interstitial fluid, develops when there is high microvascular filtration rate, low lymph flow, or both. When the cause is primarily a failure in the lymphatic drainage, it is called lymphedema.[1] Lymphedema can be primary or secondary. While primary lymphedema is caused by genetic abnormalities affecting the lymphatic development and/or function, secondary lymphedema occurs when previously normal lymphatics are subjected to external insults such as systemic disorders, infection, trauma, or surgery.[2]

Lymphatics remove and transport circulating fluid and molecules from extracellular spaces to lymph nodes. In the skin, normally functioning lymphatics are essential for prompt clearance of pathogens that cross the skin barrier and enter the subcutaneous compartment. In other tissues, they maintain extracellular fluid balance.[3,4]

When the normal flow through the lymphatic vessels is impaired, protein rich fluid accumulates, mostly in the subcutaneous compartment. This, in turn, increases the risk of infections such as erysipelas and cellulitis. The accompanying inflammatory edema worsens the preexisting edematous stage. The fluid rich stage gradually progresses to the stage of elephantiasis characterized by enlargement and fibrosis of the subcutaneous compartment and hyperkeratosis of the skin.[5]

Although these changes can be caused by congenital factors (primary lymphedema), a more common occurrence is secondary lymphedema. Cancer treatments necessitating lymph node removal or irradiation are the common causes for secondary lymphedema in developed countries and affects 15%–80% of all cancer survivors.[6] However, at the global level, lymphatic filariasis (the most common cause for secondary lymphedema in the developing countries) remains the major underlying cause for secondary lymphedema.[7] In both etiologies, the symptoms may be delayed up to months or years after the precipitating event.[3]

In addition to the two major causes, trauma, surgeries, infections, and tumors can lead to secondary lymphedema.[3] Established lymphedema, irrespective of the underlying cause, is an irreversible condition warranting lifelong care and support from family and society. The disfiguring and disabling symptoms impair the quality of life which can lead to depression in the affected. Poor access to treatment facilities (especially in the developing world) and limited information on treatment modalities available and lack of evidence on the efficacy of treatment pose major obstacles in offering relief to the affected.[3]

This symposium on “secondary lymphedema” is an attempt to bridge the gaps in the knowledge regarding this entity. Three in depth review articles dealing with pathogenesis, diagnosis and management and recent advances in treatment of lymphedema respectively are included in this symposium. We believe that these reviews would provide the much needed information to the readers.

Declaration of patient consent

Not required as there are no patients in this article.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

  1. , . Disorders of the lymphatic vessels In: , , , , , eds. Rook's Textbook of Dermatology Vol 105. (9th ed). United Kingdom: John Wiley and Sons Limited; . p. :1-63.
    [Google Scholar]
  2. . Cutaneous changes in arterial, venous, and lymphatic dysfunction In: , , , , , , eds. Fitzpatrick's Dermatology Vol 148. (9th ed). Chicago: McGraw-Hill Education; . p. :2669-99.
    [Google Scholar]
  3. , , . Self-care for management of secondary lymphedema: A systematic review. PLoS Negl Trop Dis. 2016;10:e0004740.
    [CrossRef] [PubMed] [Google Scholar]
  4. The diagnosis and treatment of peripheral lymphedema: 2009 consensus document of the international society of lymphology. Lymphology. 2009;42:51-60.
    [Google Scholar]
  5. . Lymphedema. Am J Med. 2001;110:288-95.
    [CrossRef] [Google Scholar]
  6. , , . Lymphoedema: Estimating the size of the problem. Palliat Med. 2005;19:300-13.
    [CrossRef] [PubMed] [Google Scholar]
  7. . Clinical and pathological aspects of filarial lymphedema and its management. Korean J Parasitol. 2008;46:119-25.
    [CrossRef] [PubMed] [Google Scholar]

Fulltext Views
237

PDF downloads
166
View/Download PDF
Download Citations
BibTeX
RIS
Show Sections